NCT06931847Not yet recruiting
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
SUstaiNable inteRventions and Healthy behavIours for adoleScent Primary prEvention of Cancer With Digital Tools. Study 2: Multiple Behaviour Intervention Platform
Source: ClinicalTrials.gov · Last updated 17 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among adolescents. By integrating cutting-edge digital tools with traditional educational settings, SUNRISE seeks to bridge the gap between knowledge and practice, making cancer prevention a tangible and achievable goal for young people. This study represents a significant step towards reducing the future burden of cancer through early and innovative preventive measures. The SUNRISE project aims to test its interventions on students across eight European countries, including Greece, Switzerland, Slovenia, Spain, Cyprus, Italy, Belgium, and Romania. This study focuses on integrating a unique, digitally enhanced program combining different digital solutions with new methods to change adolescent health behaviour through social media campaigns, social bot platforms, educational games, and health-related advertising content into the school environment, targeting students aged 10 to 19 years. The program emphasizes inclusivity, ensuring participation from both urban and rural regions and socially disadvantaged groups such as ethnic minorities and migrants. By addressing diverse socio-economic, cultural, and environmental contexts, SUNRISE aspires to create a universally applicable and impactful intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 5 Dec 2024
- Start date
- Sept 2025
- Primary completion date
- Mar 2027
- Lead sponsor
- Biobizkaia Health Research Institute
- Diseases
- Childhood cancers
- NCT number
- NCT06931847
What you commit to
- Study type: Observational
- Planned participants: 4000
- From Sept 2025 to the primary completion date, Mar 2027
- 8 sites in 8 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age Restrictions: Students who are younger than 10 years or older than the established age range for participation.
Other
- Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
- Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
Who the study is looking for
- Minimum Age: Students must be at least 10 years old at the time of enrolment.
- Devices and Internet Access: Students must have access to an electronic device with Internet connectivity.
- Informed Consent: Students must provide their signed informed consent to participate in the study.
- Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian.
Age in the registry: 10 years to 19 years · Sex: All · Accepts healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent University (UGENT) Coordinator of this site? Confirm its status | Zürich | Belgium | Unknown status |
| Swiss Research Institute for Public Health and Addiction (ISGF) Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
| Cyprus Association of Cancer Patients and Friends (PASYKAF) Coordinator of this site? Confirm its status | Nicosia | Cyprus | Unknown status |
| Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio) Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
| Hellenic Mediterranean University (HMU) Coordinator of this site? Confirm its status | Heraklion | Greece | Unknown status |
| Italian Federation of Voluntary Associations in Oncology (FAVO) Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
| Institute of Oncology "Prof dr. Ion Chiricuta" CLUJ NAPOCA (IOCN) Coordinator of this site? Confirm its status | Cluj-Napoca | Romania | Unknown status |
| Alma Mater Europaea University (AMEU) Coordinator of this site? Confirm its status | Maribor | Slovenia | Unknown status |
Related publications
- Strengthening cancer prevention in european schools: a randomized controlled trial of digital interventions in adolescents: the SUNRISE program.BMC Public Health · 2026 · PMID 42351094
This page is information, not medical advice. Discuss any trial with your doctor.